{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T18:02:24Z","timestamp":1791741744699,"version":"4.3.4"},"reference-count":99,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["ascpt.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["CPT Pharmacom &amp; Syst Pharma"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Drug repurposing presents a cost\u2010effective and time\u2010efficient strategy to identify new therapeutic applications for existing drugs. Recent advances in artificial intelligence, including machine learning, deep learning, knowledge graphs, and natural language processing, have revolutionized this field by enabling automated discovery of drug\u2010disease associations. This review examines the role of artificial intelligence in drug repurposing, drawing insights from two critical case areas: Coronavirus disease 2019 and oncology. We explore current trends, methodological frameworks, and technological innovations in artificial intelligence\u2010driven drug repurposing, as well as challenges and emerging future directions. The findings of this paper underscore the transformative potential of artificial intelligence in biomedical research and justify its continued integration in pharmaceutical pipelines.<\/jats:p>","DOI":"10.1002\/psp4.70272","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T13:27:54Z","timestamp":1782739674000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A Narrative Review of Artificial Intelligence for Drug Repurposing: Lessons From\n                    <scp>COVID<\/scp>\n                    \u201019 and Oncology (2020\u20132025)"],"prefix":"10.1002","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-8546-3233","authenticated-orcid":false,"given":"Alaba Bukola","family":"Ogungbite","sequence":"first","affiliation":[{"name":"Department of Computer Science University of South Africa  Florida South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5617-768X","authenticated-orcid":false,"given":"Malusi","family":"Sibiya","sequence":"additional","affiliation":[{"name":"Department of Computer Science University of South Africa  Florida South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.5281\/zenodo.15396590"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202411325"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2018.168"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41573\u2010019\u20100024\u20105"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph16060891"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.58647\/DRUGREPO.24.1.0004"},{"key":"e_1_2_9_8_1","unstructured":"A.Devereson D.Champagne E.Briggs et\u00a0al. \u201cHow Scientific AI is Unlocking Hidden Value in Drug Repurposing\u201d."},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c01077"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/s42256\u2010020\u201000236\u20104"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2020.10.010"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41573\u2010019\u20100050\u20103"},{"key":"e_1_2_9_13_1","unstructured":"K.Huang N. P.Singh andA.Gangawr \u201cTherapeutics Data Commons: Machine Learning Datasets and Tasks for Drug Discovery and Development. NeurIPS 2021 Datasets and Benchmarks Track 2023\u201d."},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab159"},{"key":"e_1_2_9_15_1","unstructured":"PatSnap Synapse \u201cHow is AI Used for Drug Repurposing in Biopharma? PatSnap\u201d."},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41421\u2010020\u20100153\u20103"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467\u2010021\u201022193\u20101"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202012697"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(20)30304\u20104"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jproteome.0c00316"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598\u2010021\u201002353\u20105"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2021.103696"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41597\u2010021\u201000975\u20100"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467\u2010019\u201010744\u20106"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbab390"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bty452"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neucom.2021.04.039"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bty294"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159\u20108290.CD\u201023\u20101199"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159\u20108290.CD\u201021\u20100090"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2020.11.037"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.chemrestox.8b00316"},{"key":"e_1_2_9_33_1","unstructured":"FDA Guidance \u201cArtificial Intelligence and Machine Learning in Software as a Medical Device \u201dhttps:\/\/www.fda.gov\/medical\u2010devices\/software\u2010medical\u2010device\u2010samd\/artificial\u2010intelligence\u2010and\u2010machine\u2010learning\u2010software\u2010medical\u2010device."},{"key":"e_1_2_9_34_1","unstructured":"European Medicines Agency \u201cReflection Paper on the Use of Artificial Intelligence in the Lifecycle of Medicines \u201dhttps:\/\/www.ema.europa.eu\/en\/use\u2010artificial\u2010intelligence\u2010lifecycle\u2010medicines."},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41587\u2010022\u201001618\u20102"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41587\u2010021\u201001145\u20106"},{"key":"e_1_2_9_37_1","unstructured":"McKinsey & Company \u201cGenerative ai in Biopharma: From Molecule to Market \u201dhttps:\/\/www.mckinsey.com\/industries\/life\u2010sciences\/our\u2010insights\/generative\u2010ai\u2010in\u2010biopharma."},{"key":"e_1_2_9_38_1","unstructured":"World Economic Forum \u201cThe Future Of Drug Discovery: ai and Quantum Computing \u201dhttps:\/\/www.weforum.org\/reports\/future\u2010of\u2010drug\u2010discovery."},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/s42979\u2010021\u201000592\u2010x"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2025.123814"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598\u2010025\u201002773\u20107"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules30142992"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12864\u2010024\u201010499\u20105"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1297924"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11030\u2010025\u201011214\u20106"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb3405"},{"key":"e_1_2_9_47_1","article-title":"Large\u2010Scale Ligand\u2010Based Virtual Screening for Sars\u2010Cov\u20102 Inhibitors Using Deep Neural Networks","author":"Hofmarcher M.","year":"2021","journal-title":"arXiv preprint"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.accounts.0c00699"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.01.021"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbac404"},{"key":"e_1_2_9_51_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1602189"},{"key":"e_1_2_9_52_1","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.70017"},{"key":"e_1_2_9_53_1","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.26726"},{"key":"e_1_2_9_54_1","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bby117"},{"key":"e_1_2_9_55_1","unstructured":"Q.Yu P.He S.Zhang et\u00a0al. \u201cDrug Repurposing System and Method Based on Heterogeneous Association Network Deep Learning \u201dWorld Intellectual Property Organization Patent No. WO2023077854A1 published May 11 2023."},{"key":"e_1_2_9_56_1","unstructured":"L.YangandH.Chen \u201cDrug Repositioning Method and System Fusing Multi\u2010Source Knowledge Graph \u201dWorld Intellectual Property Organization Patent No. WO2024138803A1 published July 4 2024."},{"key":"e_1_2_9_57_1","unstructured":"DrugPatentWatch \u201cAI and Machine Learning in Drug Repurposing \u201dDrugPatentWatch Blog accessed 2026 https:\/\/www.drugpatentwatch.com\/blog\/the\u2010role\u2010of\u2010artificial\u2010intelligence\u2010ai\u2010and\u2010machine\u2010learning\u2010ml\u2010in\u2010drug\u2010repurposing."},{"key":"e_1_2_9_58_1","unstructured":"Eli Lilly and CompanyandIncyte \u201cFDA Approves Lilly and Incyte's OLUMIANT\u00ae (Baricitinib) as First and Only Systemic Medicine for Adults with Severe Alopecia Areata \u201dPress Release June 13 2022 Lilly Investor Relations."},{"key":"e_1_2_9_59_1","doi-asserted-by":"publisher","DOI":"10.26434\/chemrxiv\u20102024\u2010fmf9k"},{"key":"e_1_2_9_60_1","first-page":"742","volume-title":"Complex Networks & Their Applications X, Studies in Computational Intelligence 1016","author":"Cohen S.","year":"2022"},{"key":"e_1_2_9_61_1","doi-asserted-by":"publisher","DOI":"10.1145\/3711896.3737011"},{"key":"e_1_2_9_62_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598\u2010025\u201007303\u2010z"},{"key":"e_1_2_9_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2021.08.002"},{"key":"e_1_2_9_64_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12032\u2010025\u201002811\u20104"},{"key":"e_1_2_9_65_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13040\u2010025\u201000466\u20105"},{"key":"e_1_2_9_66_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules30142985"},{"key":"e_1_2_9_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2025.125789"},{"key":"e_1_2_9_68_1","unstructured":"Deloitte \u201cAI in Pharma and Life Sciences \u201dDeloitte https:\/\/www.deloitte.com\/us\/en\/industries\/life\u2010sciences\u2010health\u2010care\/articles\/ai\u2010in\u2010pharma\u2010and\u2010life\u2010sciences.html."},{"key":"e_1_2_9_69_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41540\u2010022\u201000250\u20109"},{"key":"e_1_2_9_70_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41746\u2010022\u201000561\u20105"},{"key":"e_1_2_9_71_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph18070982"},{"key":"e_1_2_9_72_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598\u2010023\u201029208\u20105"},{"key":"e_1_2_9_73_1","doi-asserted-by":"publisher","DOI":"10.21037\/tcr\u20102024\u20102563"},{"key":"e_1_2_9_74_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12575\u2010025\u201000286\u20101"},{"key":"e_1_2_9_75_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2025.101426"},{"key":"e_1_2_9_76_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41573\u2010025\u201001164\u2010x"},{"key":"e_1_2_9_77_1","unstructured":"Global Insight Services \u201cAI for Drug Repurposing Market Analysis and Forecast to 2034 \u201dGlobal Insight Services January 2025 Report Code: GIS10829 https:\/\/www.globalinsightservices.com\/reports\/ai\u2010for\u2010drug\u2010repurposing\u2010market."},{"key":"e_1_2_9_78_1","unstructured":"H. J.Koo S.Han C.Son et\u00a0al. \u201cMethod of Predicting Disease Gene or Protein Related to Queried Entity and Prediction System Built by Using the Same \u201dWorld Intellectual Property Organization Patent No. WO2021154060A1 published August 5 2021."},{"key":"e_1_2_9_79_1","unstructured":"Exscientia \u201cExscientia Announces First AI\u2010Designed Immuno\u2010Oncology Drug to Enter Clinical Trials \u201dPress Release April 9 2021 https:\/\/www.businesswire.com\/news\/home\/20210408005918\/en\/Exscientia\u2010Announces\u2010First\u2010AI\u2010Designed\u2010Immuno\u2010Oncology\u2010Drug\u2010to\u2010Enter\u2010Clinical\u2010Trials."},{"key":"e_1_2_9_80_1","unstructured":"Insilico Medicine \u201cFirst Generative AI Drug Begins Phase II Trials with Patients \u201dInsilico Medicine Blog July 1 2023 https:\/\/insilico.com\/blog\/first_phase2."},{"key":"e_1_2_9_81_1","unstructured":"BenevolentAI \u201cAnnual Report and Accounts 2023 \u201d(BenevolentAI 2024) https:\/\/www.benevolent.com\/investors\/reports\u2010presentations."},{"key":"e_1_2_9_82_1","doi-asserted-by":"publisher","DOI":"10.48550\/arXiv.1510.02855"},{"key":"e_1_2_9_83_1","unstructured":"R. M.Califf \u201cHarnessing The Potential Of Artificial Intelligence \u201d 2024 https:\/\/www.fda.gov\/news\u2010events\/fda\u2010voices\/harnessing\u2010potential\u2010artificial\u2010intelligence."},{"key":"e_1_2_9_84_1","unstructured":"Drug Target Review \u201cFDA Greenlights AI\u2010Developed Drug Targeting Solid Tumors \u201dDrug Target Review December 4 2024 https:\/\/www.drugtargetreview.com\/fda\u2010greenlights\u2010ai\u2010developed\u2010drug\u2010targeting\u2010solid\u2010tumors\/644456.article."},{"key":"e_1_2_9_85_1","unstructured":"National Science Review \u201cFoundation Models in Bioinformatics. (Review Article on Large\u2010Scale Pretraining Across Genomics\/Proteomics\/Chemistry and Implications for Generalization in Biology) \u201dhttps:\/\/academic.oup.com\/nsr\/article\/12\/4\/nwaf028\/7979309."},{"key":"e_1_2_9_86_1","unstructured":"Nature Medicine \u201cA Foundation Model for Clinician\u2010Centered Drug Repurposing. (Example of Protein\u2010Language\/Multimodal Models Applied to Indication Ranking and Triage) \u201dhttps:\/\/www.nature.com\/articles\/s41591\u2010024\u201003233\u2010x."},{"key":"e_1_2_9_87_1","unstructured":"arXiv \u201cGraph Neural Networks in Modern AI\u2010aided Drug Discovery. (Survey Describing KG\/GNN Backbones for Molecular Properties Interaction Networks Synergy Prediction and Integration With Foundation Models) \u201dhttps:\/\/arxiv.org\/abs\/2506.06915."},{"key":"e_1_2_9_88_1","unstructured":"U.S \u201cFood & Drug Administration. Artificial Intelligence\u2010Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations. (Draft guidance; describes total product lifecycle (TPLC) approaches for AI\/ML in medical products) \u201dhttps:\/\/www.fda.gov\/media\/184856\/download."},{"key":"e_1_2_9_89_1","unstructured":"Nixon Law Group \u201cFDA's New Playbook for AI in Medical Devices: What Developers Need to Know \u201dJune 25 2025 https:\/\/www.nixonlawgroup.com\/resources\/fdas\u2010new\u2010playbook\u2010for\u2010ai\u2010in\u2010medical\u2010devices\u2010what\u2010developers\u2010need\u2010to\u2010know."},{"key":"e_1_2_9_90_1","doi-asserted-by":"publisher","DOI":"10.1098\/rsos.250646"},{"key":"e_1_2_9_91_1","unstructured":"BellBrook Labs \u201cHow AI and Automation Are Changing Drug Discovery \u201dBellBrook Labs November 7 2025 https:\/\/bellbrooklabs.com\/how\u2010ai\u2010and\u2010automation\u2010are\u2010changing\u2010drug\u2010discovery."},{"key":"e_1_2_9_92_1","doi-asserted-by":"publisher","DOI":"10.48550\/arXiv.2406.10729"},{"key":"e_1_2_9_93_1","unstructured":"IBM Research \u201cBiomedical Foundation Models \u201dIBM Research https:\/\/research.ibm.com\/projects\/biomedical\u2010foundation\u2010models."},{"key":"e_1_2_9_94_1","unstructured":"Therapeutics Data Commons (TDC) \u201cBenchmark Suite for Therapeutics: Standards for Reproducibility Leakage\u2010Aware Splits Temporal Scaffolds and Clinically Aligned Metrics \u201dhttps:\/\/tdcommons.ai."},{"key":"e_1_2_9_95_1","unstructured":"Global Market Insights \u201cAI in Drug Discovery Market. (Market Analysis and Projections that Illustrate Multi\u2010Fold Growth Scenarios) \u201dhttps:\/\/www.gminsights.com\/industry\u2010analysis\/ai\u2010in\u2010drug\u2010discovery\u2010market."},{"key":"e_1_2_9_96_1","unstructured":"Precedence Research\/BioSpace press coverage \u201cAI in Drug Discovery Market Size Projections. (Alternate Market Forecast Supporting Growth Claims) \u201dhttps:\/\/www.biospace.com\/press\u2010releases\/ai\u2010in\u2010drug\u2010discovery\u2010market\u2010size\u2010to\u2010worth\u2010usd\u201016\u201052\u2010bn\u2010by\u20102034."},{"key":"e_1_2_9_97_1","unstructured":"Recursion \u201cRecursion and Exscientia: Two Leaders in AI Drug Discovery Space \u201dPress Release https:\/\/ir.recursion.com\/news\u2010releases\/news\u2010release\u2010details\/recursion\u2010and\u2010exscientia\u2010two\u2010leaders\u2010ai\u2010drug\u2010discovery\u2010space."},{"key":"e_1_2_9_98_1","unstructured":"Ardigen\/industry perspective \u201cFoundational Models for AI in Biology. (Article Describing Enterprise Adoption of Generative and Graph Stacks for Discovery) \u201dhttps:\/\/ardigen.com\/foundational\u2010models\u2010for\u2010ai\u2010in\u2010biology\u20102."},{"key":"e_1_2_9_99_1","unstructured":"JACS Au \u201cA Perspective on Foundation Models in Chemistry. (Reviews Scaling of Chemistry Foundation Models and Outlook for High\u2010Fidelity Simulation) \u201dhttps:\/\/pubs.acs.org\/doi\/10.1021\/jacsau.4c01160?utm_source=chatgpt.com."},{"key":"e_1_2_9_100_1","doi-asserted-by":"publisher","DOI":"10.26434\/chemrxiv\u20102025\u2010f1hgn"}],"container-title":["CPT: Pharmacometrics &amp; Systems Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/psp4.70272","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/psp4.70272","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/psp4.70272","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T11:24:43Z","timestamp":1784201083000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1002\/psp4.70272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":99,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1002\/psp4.70272"],"URL":"https:\/\/doi.org\/10.1002\/psp4.70272","archive":["Portico"],"relation":{},"ISSN":["2163-8306","2163-8306"],"issn-type":[{"value":"2163-8306","type":"print"},{"value":"2163-8306","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"2025-12-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-11","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70272"}}